glutathione to s adenosylhomocysteine S-Adenosylmethionine: A Multifaceted Regulator in Cancer Pathogenesis and Therapy SAH (SAH (S-Adenosylhomocysteine)) | METTL3-14
Description
(802) Cieliska, A
The results were consistent with the peptide ending at leucine 607
If you experience any suspected side effects from supplements or medicines, report them via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app
Embodiment 200 A cell comprising the expression vector of embodiment Embodiment 201 A chimeric antigen receptor (CAR) comprising an antibody according to any one of embodiments 1-135
